ELFBAR Apologizes and Commits to Compliance in UK Market

Elfbar by 2FIRSTS.ai
Feb.13.2023
ELFBAR Apologizes and Commits to Compliance in UK Market
ELFBAR apologized for non-compliance issues with ELF Bar 600 and promised to withdraw non-compliant products from the UK market.

On February 10th, ELFBAR held a meeting with the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK, with the attendance of the UK Vaping Industry Association (UKVIA) and the Independent British Vape Trade Association (IBVTA).


During the meeting, ELFBAR apologized for the "ELFBAR 600 compliance issue" and promised to rectify the mistake to ensure the compliance of ELFBAR 600 in the UK market. This attitude was supported by UKVIA and IBVTA.


ELFBAR has stated that it will be pulling its non-compliant ELFBAR 600 product from the UK market in accordance with MHRA regulations.


Meanwhile, ELFBAR has published a public statement through the official media accounts of IBVTA and UKVIA. The statement reads as follows:


Today, following a meeting with the Medicines and Healthcare products Regulatory Agency (MHRA) convened by ELFBAR, we are providing you with the latest information about the product.


Recently, there have been news reports questioning the compliance of ELFBAR 600 in the UK market. In response to these questions, we conducted a thorough investigation of ELFBAR 600 in the UK market and found that some of the products contained e-juice that exceeded regulations. Although this issue means the products are not fully compliant with UK regulations, we did not find any issues with nicotine concentration or products that would potentially harm consumer safety.


Today, we met with the Medicines and Healthcare products Regulatory Agency to discuss the matter and confirm that corrective measures are in place to ensure ELFBAR 600 compliance in the UK market. We received support from the UK Vaping Industry Association and the Independent British Vape Trade Association during the meeting. We made it clear that we have a responsibility to rectify the situation and acknowledge that we fell short in some areas. Despite the flaws, the MHRA agrees that the issue does not pose any safety concerns but still violates UK regulations.


The MHRA has recommended the withdrawal of the ELFBAR 600 from the market. We have agreed with this recommendation and will voluntarily withdraw the non-compliant product from the UK market. We will work with a trade standards body to ensure an effective withdrawal process with minimal market disruption. We will also update all of our distribution and retail partners once we have agreed on the implementation of this corrective measure.


Although investigations and corrective measures for the ELFBAR 600 are ongoing, we are also committed to investigating all other e-cigarette products we export to the UK. We will take any necessary action to ensure compliance across our entire product range.


We are grateful for the support of MHRA in this urgent and important matter, and we appreciate the opportunity to collaborate to ensure that all of our products fully comply with UK regulations. We have committed to further meetings with MHRA to ensure that our products meet the necessary requirements.


I'm sorry, but "ELFBAR" cannot be translated to standard journalistic English as it does not appear to be a word or phrase in the English language. Can you please provide additional context or clarify what you are trying to translate?


Previously, 2FIRSTS attempted to conduct an interview with employees of ELFBAR, but their request was declined. Currently, 2FIRSTS has reached out to MHRA, UKVIA, and IBVTA for interview opportunities and will continue to monitor and report on this issue. Stay tuned.


ELFBAR Statement | Image Source: Twitter


For more related reading, please refer to the comprehensive collection of articles titled "ELFBAR 600 Product Removal".


Reference:


The company responsible for producing the ELF Bar 600 has issued a statement.


ELF Bar has issued a statement following their meeting with the Medicines and Healthcare products Regulatory Agency (MHRA) today.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Wisconsin Vape Directory One Year On: Retailer Reports Four Store Closures and 70% Staff Cuts
Wisconsin Vape Directory One Year On: Retailer Reports Four Store Closures and 70% Staff Cuts
Wisconsin's electronic vaping device directory has been fully enforced for more than a year, and local vape retailers say the reduced range of eligible products has contributed to declining sales, store closures and layoffs. Johnny Vapes owner Ben Hall said he has closed four of seven locations and cut about 70% of his staff. State law bars the sale of vaping devices not listed on the Wisconsin Department of Revenue directory and allows penalties of $1,000 per day for each unlisted device sold or offered for sale. In April 2026, the U.S. Court of Appeals for the Seventh Circuit allowed enforcement of the law to continue.
Regulations
Oct.10
Ukraine Raises Excise Stamp Fees for Tobacco, Heated Tobacco and Vape Liquids by 30.5% as Parliament Backs E-Excise Delay to 2027
Ukraine Raises Excise Stamp Fees for Tobacco, Heated Tobacco and Vape Liquids by 30.5% as Parliament Backs E-Excise Delay to 2027
Ukraine's Cabinet of Ministers adopted Resolution No. 1259 on October 15, 2026, increasing excise stamp production fees for tobacco products and e-cigarette liquids by approximately 30.5%, from UAH 0.1643 to UAH 0.2144 per stamp. Fees for alcoholic beverages rose by about 30.2%. Separately, Ukraine's parliament passed Bill No. 15532 on October 13, proposing to postpone the full implementation of electronic excise stamps and traceability for alcohol, tobacco and e-cigarette liquids from November 1, 2026, to July 1, 2027. Parliament cited additional testing, configuration and integration requirements. The bill was sent to the president for signature on October 19.
Regulations
Oct.21
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
FDA’s Center for Tobacco Products is reshaping how it approaches tobacco product review. Based on 2Firsts’ on-site reporting in New York and Washington, this report traces CTP’s emerging direction: stronger links between PMTA and tobacco harm reduction, more category-specific review, greater emphasis on decision-relevant science, more predictable timelines and expanded use of sPMTA for product modifications. CTP also acknowledged major constraints, including just nine PMTA review teams, persistent backlogs and limits on hiring capacity.
Regulations
Oct.08
Product | BAT Launches VELO WRKS Nicotine Pouches in Sweden, Introducing Dual-Compartment Cans With Two Flavours
Product | BAT Launches VELO WRKS Nicotine Pouches in Sweden, Introducing Dual-Compartment Cans With Two Flavours
British American Tobacco (BAT)'s VELO brand launched the VELO WRKS nicotine pouch range in Sweden on November 2, 2026. The initial release features three Dual Can variants, each containing two separate flavours in a dual-compartment container. Each can holds 20 slim pouches with 8mg of nicotine per pouch and retails for SEK 52.99. According to VELO, the first release, Drop 1, is limited to 75,000 cans and will remain available until February 2027 or while stocks last. VELO positions WRKS as a platform for testing new product concepts and has introduced an online consumer feedback survey. EU trademark records show BAT applied to register VELO WRKS in March 2026 under Class 34, covering nicotine pouches, e-cigarettes, heated tobacco products and other tobacco-related goods.
product
Nov.03
Japan's Heated Tobacco Use Rises From 0.1% to 14.9% Over a Decade as Growth Extends Beyond Cigarette Switching
Japan's Heated Tobacco Use Rises From 0.1% to 14.9% Over a Decade as Growth Extends Beyond Cigarette Switching
A decade-long study published in The Lancet Regional Health – Western Pacific found that heated tobacco product use in Japan increased from 0.1% in 2015 to 14.9% in 2025, although growth slowed after 2018. Switching from conventional cigarettes remained an important source of HTP uptake, while the contribution from previously non-current users increased. Approximately 56% of HTP users also smoked conventional cigarettes in 2025. Separate industry data show that Japan's heated tobacco sales reached 73.4 billion units in fiscal 2025, approaching conventional cigarette sales of 78.2 billion units.
SCIENCE
Nov.10
Product|AIR Files U.S. PMTA for Crown Switch. Can Greentank's Chip Technology Deliver a Compliance and Competitive Advantage?
Product|AIR Files U.S. PMTA for Crown Switch. Can Greentank's Chip Technology Deliver a Compliance and Competitive Advantage?
AIR Global PLC (NASDAQ: AIIR) announced on November 5, 2026, that it had submitted a Premarket Tobacco Product Application (PMTA) to the U.S. Food and Drug Administration (FDA) for Crown Switch, its rechargeable pod vape platform. First launched in Germany in November 2025, the device uses Quantum Chip atomization technology developed by Canadian vaporization technology company Greentank Innovations. German retail versions feature 2mL prefilled pods containing 18mg/mL nicotine in six flavors, while AIR has separately tested two 5% nicotine formulations intended for U.S. development. AIR invested $20 million in Greentank in July and reported approximately $3.4 million in U.S. PMTA-related regulatory costs for the first nine months of 2026. The Crown Switch application has been submitted, but the FDA has not granted marketing authorization.
product
Nov.13